Ramish Cheema
3 min read
In This Article:
Eli Lilly and Company (NYSE:LLY) is one of the Jim Cramer Reveals Potential US Rare Earth Trump Card & Discusses These 11 Stocks.
Eli Lilly and Company (NYSE:LLY) is one of the most frequently discussed stocks on Cramer’s morning show. He is a fan of the firm not only due to its lead in the weight loss market but also due to its drug pipeline. During his earlier appearances, Cramer has commented on Eli Lilly and Company (NYSE:LLY)’s plans to establish manufacturing facilities for its products and its plan to introduce a weight loss pill. This time around, he commented on Eli Lilly and Company (NYSE:LLY) in the context of Novo Nordisk and activist fund Parvus taking a stake in Novo:
“[On activist fund Parvus building a stake in Novo] How could they be so far behind? You know they were first, they were first mover. And then Lilly came along, Lilly by the way, still a great stock. But maybe this is going to shake up Novo.
In his previous remarks about Eli Lilly and Company (NYSE:LLY), Cramer discussed weight loss drugs:
“I want you to buy more… The reason why you want to buy it is because there was definitive data that came out last night about Novo Nordisk not being anywhere near as good as Eli Lilly when it comes to weight loss, which is what a lot of people are in the GLP for. And it was not reflected because the things were so crazed because of what the president announced. I think the stock could be up a hundred points when people realize, wait a second, it is definitively better than Novo. I would buy Eli Lilly hand over fist.”
An array of pharmaceutical pills with the company's logo on the bottle.
While we acknowledge the potential of LLY as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock.
